Skip to main content

Table 1 Patient demographics and clinical characteristics

From: A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

Patients evaluated N = 99
Female, % 62
Median age, years 51.9
Patients alive at time of data abstraction, % 37
History of surgery, % 87
Histological subtype, %  
  Leiomyosarcoma 48
  Synovial cell sarcoma 7
  Liposarcoma 5
  Other: 39
  Alveolar soft part sarcoma 5
  Clear cell sarcoma 4
  Dedifferentiated liposarcoma 4
  Solitary fibrous tumor 4
  Endometrial stromal sarcoma 4
  Adenosarcoma 3
  Carcinosarcoma 2
  Fibrous histiocytoma 2
  PEComa 2
  Epithelioid and round cell malignant neoplasm, desmoplastic   small round-cell sarcoma, epithelioid sarcoma, epithelioid   hemangioendothelioma, myxoid liposarcoma, rhabdomyosarcoma,   round cell sarcoma, spindle cell sarcoma, undifferentiated sarcoma,   and uterine sarcoma 1 Each
Reason for discontinuing second-line therapy, %  
  Progressive disease 73
  Completed therapy course 10
  Adverse events 6
  Surgery 2
  Death 1
  Developed second primary malignancya 1
  Patient request 1
  Avoidance of cumulative toxicity 1
  Unclear 6
  1. aOne patient developed a new primary colon carcinoma.